TAYLOR DRYDEN: Open Payments
NPI 1710555180 · LINCOLN, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$7,425 in 341 payments from 21 companies in 2025. Trend: 2023 $522 · 2024 $6,427 · 2025 $7,425
Food & beverage: $7,213Education: $212
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 64 | $1,441 |
| ABBVIE INC. | 79 | $1,039 |
| LEO Pharma Inc. | 31 | $893 |
| Novartis Pharmaceuticals Corporation | 30 | $679 |
| UCB, Inc. | 15 | $519 |
| Regeneron Healthcare Solutions, Inc. | 14 | $479 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 16 | $329 |
| Galderma Laboratories, L.P. | 18 | $260 |
| PFIZER INC. | 9 | $246 |
| Amgen Inc. | 9 | $246 |
Products named: TREMFYA, SKYRIZI, ADBRY, DUPIXENT, Bimzelx, COSENTYX, RINVOQ, CIBINQO.
Industry payments across RI — which companies pay providers there.
